Skip to content

Minimizing Ventricular Pacing

Minimizing Right Ventricular Pacing in Dual-chamber Pacemaker Patients With Sinus Node Disease and First Degree Atrioventricular Block.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01611389
Enrollment
60
Registered
2012-06-05
Start date
2010-09-30
Completion date
2012-12-31
Last updated
2012-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First Degree Atrioventricular Block., Sinus Node Disease.

Brief summary

The aim of this study is to evaluate the effect of minimizing right ventricular pacing in dual-chamber pacemaker patients with sinus node disease (SND) and first degree atrioventricular block (AVIB)on exercise capacity, quality of life and other heart failure measures.

Interventions

DEVICEProlonging atrioventricular (AV) delay.

Prolonging atrioventricular (AV) delay to maximum 350 ms.

DEVICEStandard atrioventricular (AV) delay.

Standard atrioventricular (AV) delay - approximately 180/140 ms depending on heart rate.

Sponsors

Military Institute od Medicine National Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* prolonged PQ interval \> 200 ms, * percentage of right ventricular pacing with standard AV delay \> 90.

Exclusion criteria

* second or third degree atrioventricular block, * permanent atrial fibrillation.

Design outcomes

Primary

MeasureTime frame
Oxygen uptake (cardiopulmonary exercise testing).3 months

Secondary

MeasureTime frameDescription
Left ventricular ejection fraction.3 monthsAssessed in echocardiography.
Quality of life3 monthsSF36 questionnaire.
Arrhythmia3 months24 hours Holter monitoring, pacemaker storage data.
Ventilatory anaerobic threshold (cardiopulmonary exercise testing)3 months
VE/VCO2 slope (cardiopulmonary exercise testing).3 months

Countries

Poland

Contacts

Primary ContactKrystian Krzyżanowski, MD
krystian.krzyzanowski@gmail.com512 356 207

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026